K

Kuros Biosciences Tech Stack

Bone graft biologics with Level I clinical evidence

Medical Equipment Manufacturing Schlieren, Zurich 51–200 employees Public Company

Kuros develops MagnetOs, a biologic bone graft backed by dozens of Level I clinical trials across >400 patients and >25 orthobiologics patents. The hiring mix—sales-forward with active manufacturing and ops scaling—reflects a commercialization phase: the company is launching into new markets (orthopedic trauma, Europe, US) while validating a new manufacturing facility and training a distributed sales team. Pain points around cycle time, yield, and supply-chain reliability signal typical biotech manufacturing maturation challenges.

Tech Stack 10 technologies

Core StackDynamics 365 Power BI Tableau HubSpot WordPress Canva CRM Microsoft Dynamics 365 Veeva Microsoft Office

What Kuros Biosciences Is Building

◆Challenges

Flawless supply chain
Validating new manufacturing facility
Process inefficiencies
Reducing cycle time
Enhancing product reliability
Meeting sales quotas
Orthopedic trauma market entry
Equipment downtime
Improving efficiency and yield
Improving documentation quality

▲Active Projects

New product introductions
New manufacturing facility validation
Cell-based assay development
R&d to production scale-up
Magnetos market entry strategy
Product launch and training program
Supplier qualification
Capital project commissioning
Instructions for use documentation
New manufacturing facility construction

Hiring Activity

Accelerating30 roles · 15 in 30d

Department

Sales

8

Manufacturing

5

Ops

5

Research

4

Finance

1

Healthcare

1

HR

1

Logistics

1

Seniority

Mid

13

Manager

7

Senior

6

Junior

2

Director

1

Notable leadership hires: Biologics Director

Company intelligence

Find more companies like Kuros Biosciences by tech stack, pain points and active projects

Get started free

About Kuros Biosciences

Kuros Biosciences is a Swiss-listed biotech company (SIX: KURN, public since 2016) developing bone graft solutions for spine, orthopedic trauma, and foot & ankle surgery. The core product, MagnetOs, is supported by extensive clinical evidence including completed and ongoing Level I–IV randomized controlled trials. Operations span Switzerland, the Netherlands, and the US, with commercial presence in >20 markets. The company is actively expanding manufacturing capacity, scaling sales teams, and preparing product launches in new surgical segments.

HeadquartersSchlieren, Zurich

Company Size51–200 employees

Hiring MarketsNetherlands, United States

Frequently Asked Questions

What is Kuros Biosciences working on?

Primary focus: new product introductions, MagnetOs market entry strategy, and manufacturing facility validation. Active projects include cell-based assay development, R&D-to-production scale-up, product launch training, and supplier qualification.

What tech stack does Kuros Biosciences use?

Primary: Dynamics 365 (CRM, ERP), Power BI, Tableau, Veeva (regulatory/quality), HubSpot, WordPress, Canva, Microsoft Office. No active adoption or replacement initiatives recorded.